drugset
drugset / Trial / NCT03473626

Phase 1 Food Effect Study for Alicaforsen Tablets

NCT03473626 ↗

Phase 1 Completed 15 enrolled Atlantic Pharmaceuticals Ltd
RandomizedCrossoverOpen-labelBasic science

Summary

Phase 1 study to compare the effect of food on alicaforsen tablet.

Timeline

Start
2018-03-16
Primary completion
2018-04-06
Completion
2018-04-06

Drugs

EvaluationDrugModalityDoseRoute
Subject ALICAFORSEN SODIUM Unknown — —

Indications

inflammatory bowel disease